Hydrochloric Acid → 7-Benzenesulfonyl-5-methyl-4-piperazin-1-yl-7H-pyrrolo[2,3-d]pyrimidine dihydrochloride
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]2[C:15]3[C:22]([CH3:23])=[CH:21][N:20]([S:24]([C:27]4[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=4)(=[O:26])=[O:25])[C:16]=3[N:17]=[CH:18][N:19]=2)[CH2:10][CH2:9]1)=O)(C)(C)C.[ClH:33]>C(Cl)Cl>[ClH:33].[ClH:33].[C:27]1([S:24]([N:20]2[C:16]3[N:17]=[CH:18][N:19]=[C:14]([N:11]4[CH2:12][CH2:13][NH:8][CH2:9][CH2:10]4)[C:15]=3[C:22]([CH3:23])=[CH:21]2)(=[O:25])=[O:26])[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A solution of 4-(7-Benzenesulfonyl-5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-piperazine-1-carboxylic acid tert-butyl ester (4.0 g, 13 mmol) in DCM (100 mL) was treated with anhydrous HCl (4M in dioxane, 100 mL) and stirred at room temperature overnight. The suspension was concentrated in vacuo to give 7-Benzenesulfonyl-5-methyl-4-piperazin-1-yl-7H-pyrrolo[2,3-d]pyrimidine dihydrochloride (5.4 g, 100%.) LCMS (APCI+) m/z 358 [M+H]+; Rt: 1.79.
Workup
- concentrationThe suspension was concentrated in vacuo
Sources & evidence
- ORD record
- ord-5a8f3eaa9bd645c6a6f220133e32fde8
- Source dataset
- uspto-grants-2014_03
- Patent number
- US08680114B2
Reaction notes
Loading…